首页|期刊导航|临床误诊误治|卵巢癌患者临床误诊分析

卵巢癌患者临床误诊分析OA

Analysis of clinical misdiagnosis in patients with ovarian cancer

中文摘要英文摘要

目的 探讨卵巢癌临床误诊原因及防范措施,以提高临床医师诊治水平.方法 回顾性分析2020年6月-2023年6月沧州市人民医院收治的曾误诊的卵巢癌患者2例的临床资料.结果 1例绝经后女性因持续腹胀38 d就诊,初诊CT示附件囊实性占位、大量腹水及腹膜增厚,穿刺病理阴性,结合糖类抗原125、人附睾蛋白4(HE4)水平升高,疑卵巢癌但未能确诊;后续腹水脱落细胞学检查阴性,结核相关检查阳性,遂按盆腔结核待排转诊;为明确病因行腹腔镜腹膜活检,病理及免疫组织化学(PAX8、WT1、P53、P16弥漫阳性)检查确诊为卵巢浆液性癌Ⅲ C期;误诊时间5 d;确诊后给予紫杉醇+卡铂新辅助化疗4个周期后行间歇性肿瘤细胞减灭术,切除子宫双附件及网膜转移灶,术后追加2个周期化疗并予尼拉帕利维持,术后6个月随访糖类抗原125、HE4水平降至正常,无复发,预后良好.1例因"下腹痛6 h余"入院,依据临床症状及相关检查结果诊断为"黄体破裂";予以抗炎、止血保守治疗,未见缓解;后全身麻醉下实施腹腔镜探查术,术中冰冻病理检查结果考虑为卵巢癌,遂行卵巢癌全面确定分期手术;术后病理检查结果显示(右卵巢)子宫内膜样癌(中-高分化);误诊时间4 d;术后采用紫杉醇联合顺铂进行化疗,治疗2个周期后复查糖类抗原125下降;随访6个月,未发现新病灶,目前仍在持续跟踪随访中.结论 卵巢癌与盆腔结核、黄体破裂有相似的临床表现,需通过术后病理及免疫组织化学检查确诊.在临床实践中,应提高警惕,对于疑似病例进行细致的鉴别诊断,以避免误诊和漏诊.

Objective To analyze the causes of clinical misdiagnosis of ovarian cancer and its preventive measures,so as to improve the diagnostic and therapeutic level of clinicians.Methods The clinical data of three patients with misdiagnosed ovarian cancer that were treated at Cangzhou People's Hospital from June 2020 to June 2023 were retrospectively analyzed.Results A postmenopausal women presented with persistent abdominal distension for 38 d.The initial CT scan showed cystic and solid masses of adnexa,massive ascites and peritoneal thickening,while the puncture pathology was negative.Combined with elevated levels of carbohydrate antigen 125(CA125)and human epididymis protein 4(HE4),ovarian cancer was suspected but could not be definitively diagnosed.The subsequent ascites exfoliative cytology was negative,and the tuberculosis-related examinations were positive,leading to a referral for suspected pelvic tuberculosis.In order to determine the etiology,laparoscopic peritoneal biopsy was performed.Pathological and immunohistochemical findings(PAX8,WT1,P53,and P16 were diffusely positive)confirmed the diagnosis of ovarian serous carcinoma stage Ⅲ C.The misdiagnosis lasted 5 d.After 4 cycles of neoadjuvant chemotherapy with Paclitaxel and Carboplatin following the definitive diagnosis,the patient underwent interval cytoreductive surgery to resect the bilateral adnexa and omental metastases.After operation,the patient received 2 cycles of chemotherapy and maintained with Nilapamide.At 6 months after operation,CA125 and HE4 returned to normal,without recurrence,and the prognosis was good.One patient was admitted due to lower abdominal pain for more than 6 h.According to the clinical symptoms and relevant examination findings,the patient was diagnosed with corpus luteum rupture and received conservative treatment with anti-inflammatory and hemostatic agents,which did not result in symptomatic relief.Laparoscopic exploration was performed under general anesthesia.Intraoperative frozen section was suggestive of ovarian cancer,and comprehensive staging surgery for ovarian cancer was subsequently carried out.Postoperative pathological examination revealed endometrioid carcinoma(moderately to well differentiated)of the right ovary.The duration of misdiagnosis was 4 d.Paclitaxel combined with Cisplatin was used for chemotherapy after operation,and after 2 cycles,the serum CA125 level decreased.The patients were followed up for 6 months,and no new lesions were identified,and the patient continues to be followed up regularly.Conclusion Ovarian cancer has similar clinical manifestations with pelvic tuberculosis and corpus luteum rupture,which should be confirmed by postoperative pathological examination and immunohistochemical staining.In clinical practice,we should be vigilant and carry out detailed differential diagnosis for suspected cases to avoid misdiagnosis and missed diagnosis.

李博文;邵迎华;杨秀梅;赵明阳

沧州市人民医院妇科,河北沧州 061000沧州市人民医院妇科,河北沧州 061000沧州市人民医院妇科,河北沧州 061000沧州市人民医院妇科,河北沧州 061000

卵巢癌误诊盆腔结核黄体破裂鉴别诊断病理学检查糖类抗原125

ovarian cancerpelvic tuberculosiscorpus luteum rupturedifferential diagnosispathological examinationcarbohydrate antigen 125

《临床误诊误治》 2026 (16)

19-25,7

沧州市重点研发计划指导项目(23244102045)

10.3969/j.issn.1002-3429.2026.16.004

评论